Wegovy® tablets and bloating

Feeling bloated versus a swollen belly

Patient documents use plain words: the US Medication Guide lists “feeling bloated” and “gas”, and the EU tablet leaflet lists “bloating of the stomach” and “gas (flatulence)” ^[1][2]. Trial tables use the medical terms abdominal distension and flatulence. NIH draws a useful line between them: bloating is a sense of fullness or swelling in the belly, distension means the belly is actually larger than usual, and only about half of people with bloating also have distension ^[8].

Gas itself is normal. NIH explains that it comes from swallowed air and from bacteria in the large intestine breaking down carbohydrates the small intestine did not absorb, and that it becomes a problem when it is frequent, bothersome or gets in the way of daily life ^[8].

Five documents, no clean tablet number

Put side by side, the documents show where a tablet figure would be and why it is missing.

What “under 5%” can and cannot tell you

The ClinicalTrials.gov results for OASIS 4 were entered by the sponsor and are not peer reviewed. The adverse event list covers everything that began during treatment, whatever the cause, but shows a non-serious event only if it reached 5% in at least one group ^[3]. Bloating and gas are absent, so in both arms they stayed below 5%. With 204 people on the tablet, 5% is about ten people. The registry does not reveal whether the tablet group had a few more cases than placebo, the same number or fewer.

The EU document fills the gap with injection data on purpose: its frequency classes come, unless stated otherwise, from 2,650 adults in the STEP 1–4 injection trials, and it says reactions in OASIS 4 had similar frequencies except for indigestion ^[2]. The US label makes a parallel statement ^[1]. Both are reasonable regulatory summaries, but neither is a measured bloating rate for the 25 mg tablet.

The 50 mg OASIS 1 trial is the nearest oral data point. Its published report found digestive adverse events in 80% on oral semaglutide versus 46% on placebo, mostly mild to moderate ^[5], and its registry lists both bloating terms ^[4]. Because 50 mg is double the approved maintenance dose and the trial had its own population and a 68-week plan, those rates are context only.

Clues from the rest of the tablet data

Two tablet findings point in bloating’s direction. Constipation was recorded in 20.1% on the tablet and 9.8% on placebo in OASIS 4, mostly mild to moderate but longer-lasting than other digestive events ^[2], and MedlinePlus puts constipation near the top of its list of bloating causes ^[6]. Reflux disease, also on that list, was 7.8% versus 4.9% in the registry ^[3][6].

The EU table also lists delayed gastric emptying as an uncommon reaction, and the EU text warns that people with gastroparesis (a stomach that empties very slowly) may get more serious digestive effects; the US label does not recommend Wegovy® in severe gastroparesis ^[1][2].

Does the pill slow the stomach? The measurements disagree

• The US label states that semaglutide delays gastric emptying ^[1].
• In 15 adults with type 2 diabetes, oral semaglutide escalated to 14 mg slowed emptying during the first hour after a meal, seen as 31% less paracetamol absorbed in that hour ^[11].
• In 61 adults with obesity, oral semaglutide escalated to 50 mg showed no statistically significant difference in gastric emptying at week 20, by the same paracetamol method ^[12].
• Neither study measured bloating, both used doses other than 25 mg, and both come from the manufacturer’s own research programme. How much slower emptying adds to bloating on the tablet has not been shown.

Other reasons a belly feels full and tight

MedlinePlus lists swallowed air, constipation, reflux, irritable bowel syndrome, lactose intolerance and other food intolerances, overeating, bacterial overgrowth in the small intestine and weight gain as common causes, and notes that some medicines, such as the diabetes drug acarbose, can cause bloating ^[6]. NIH adds coeliac disease, gastroparesis and blockages of the digestive tract ^[8]. Less often, bloating comes from serious conditions such as fluid in the abdomen, pancreatic problems or ovarian cancer, which is why bloating that persists deserves a check ^[6].

What NIH and MedlinePlus suggest trying

The general advice is about swallowing less air and noticing triggers: eat slowly and sit down to eat; avoid chewing gum, hard sweets, straws and fizzy drinks; and consider smaller, more frequent meals ^[9][10]. Foods that commonly add gas include beans, lentils and cruciferous vegetables such as broccoli and cabbage, some fruit and juices, dairy for people with lactose intolerance, and sweeteners ending in “-ol”; NIH also notes that high-fat foods can increase bloating ^[10]. A food and symptom diary can help a doctor or dietitian spot patterns ^[10].

MedlinePlus mentions simethicone and similar over-the-counter gas remedies ^[6]. The Wegovy® label does not cover them, the tablet’s 30-minute rule applies to any oral medicine, and the Medication Guide asks you to tell your provider about non-prescription products ^[1], so check with your pharmacist first. For swallowing the tablet itself, the label allows only water, up to 4 ounces, and the manufacturer specifies plain water ^[1][13].

Wegovy® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.

When to get help